Cargando…
New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Retinal gene therapy is leading the neurological gene therapy field, with 32 ongoing clinical trials of recombinant adeno-associated virus (rAAV)–based therapies. Importantly, over 50% of those trials are using restricted promoters from human genes. Promoters that restrict expression have demonstrat...
Autores principales: | Simpson, Elizabeth M., Korecki, Andrea J., Fornes, Oriol, McGill, Trevor J., Cueva-Vargas, Jorge Luis, Agostinone, Jessica, Farkas, Rachelle A., Hickmott, Jack W., Lam, Siu Ling, Mathelier, Anthony, Renner, Lauren M., Stoddard, Jonathan, Zhou, Michelle, Di Polo, Adriana, Neuringer, Martha, Wasserman, Wyeth W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437624/ https://www.ncbi.nlm.nih.gov/pubmed/30062914 http://dx.doi.org/10.1089/hum.2018.118 |
Ejemplares similares
-
Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells
por: Korecki, Andrea J., et al.
Publicado: (2021) -
OnTarget: in silico design of MiniPromoters for targeted delivery of expression
por: Fornes, Oriol, et al.
Publicado: (2023) -
PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina
por: Hickmott, Jack W, et al.
Publicado: (2016) -
rAAV-compatible MiniPromoters for restricted expression in the brain and eye
por: de Leeuw, Charles N., et al.
Publicado: (2016) -
Evaluating the impact of single nucleotide variants on transcription factor binding
por: Shi, Wenqiang, et al.
Publicado: (2016)